Hound Labs Stock

houndlabs.comConsumer & LifestyleFounded: 2014Funding to Date: $62.21MM

Hound Labs is the developer of an ultra-sensitive breath analysis technology platform seeking to solve fundamental issues with disease and drug detection. Their HOUND® MARIJUANA BREATHALYZER is a point-of-care solution which allows employers and law enforcement to identify recent cannabis use rapidly and accurately by testing breath on-site. Hound Labs was founded in 2014 by Dr. Mike Lynn. It is currently headquartered in Oakland, California.

Register for Details

For more details on financing and valuation for Hound Labs, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Hound Labs.

Register Today

Hound Labs investors also invested in these private companies

Team

Management Team

Paul Callahan
Chief Operating Officer
Jenny Lynn
Co-Founder & Chief Medical Officer
Tom Simonson
Director of Finance & Accounting
Sobha Pisharody Ph.D
Chief Product Officer
Kuni Oh
Chief Patent Counsel & Co-Founder
Michael Lynn MD
Co-Founder, Chief Executive Officer & Board Member

Board Members

Mitch Lasky JD
Benchmark (San Francisco)
Richard Wolf
Thomas Mawhinney
Michael Lynn MD

Other companies like Hound Labs in the Consumer & Lifestyle sector

Sector
Last Round Est. Valuation
$10.38B
Sector
Last Round Est. Valuation
$4.05B
Sector
Last Round Est. Valuation
$3.51B
Sector
Last Round Est. Valuation
$793.14MM
Sector
Last Round Est. Valuation
$2.2B
Sector
Last Round Est. Valuation
$3.2B
Sector
Last Round Est. Valuation
$12.76B

News

With the growing legalization of marijuana, a number of research labs and startups are working to develop a breakthrough breathalyzer that can objectively determine whether or not a person is high. Here's why such a tool is required -- and when we can expect it to arrive.
Hound Labs, an Oakland, CA-based creator of a dual marijuana and alcohol breathalyzer, closed a $30m Series D financing round